Mumbai, Oct. 27 -- A national body of consumer packaged goods distributors has decided not to accept or pursue sales targets set by Tata Consumer Products Ltd until the company initiates a "fair dialo... Read More
New Delhi, Oct. 27 -- Gold prices continued to grind lower during Monday's trading session, October 27, extending losses after halting a nine-week winning streak amid progress in trade talks between t... Read More
New Delhi, Oct. 27 -- Americans are now paying more for their daily coffee runs after US President Donald Trump slapped sweeping tariffs on the top coffee exporter and launched an anti-drug campaign t... Read More
New Delhi, Oct. 27 -- Filmmaker and screenwriter Taylor Sheridan, the creative force behind Yellowstone, Tulsa King and several other hit dramas, is reportedly preparing to part ways with Paramount an... Read More
New Delhi, Oct. 27 -- Delhi residents on Monday woke up to cloudy skies as the met office forecast a partly cloudy with chances of very light rain towards the evening. Apart from the weather office, ... Read More
New Delhi, Oct. 27 -- Apple is preparing iOS 26.1, a quiet but meaningful change to how photos move off an iPhone. Third party apps will be able to upload images in the background, so you can start a ... Read More
New Delhi, Oct. 27 -- Japan's Nikkei share average extended rally and surpassed the 50,000 level for the first time on Monday on expectations of a sizable spending from the nation's new prime minister... Read More
New Delhi, Oct. 27 -- Cyclone Montha is very likely to cross Andhra Pradesh coast between Machilipatnam and Kalingapatnam during the evening/night of October 28 "as a severe cyclonic storm", the India... Read More
New Delhi, Oct. 27 -- Kantara Chapter 1 OTT release date OUT: Rishab Shetty's blockbuster film, Kantara Chapter 1, is all set to release on OTT. While reports about the film's OTT release had been cir... Read More
New Delhi, Oct. 27 -- Intellia Therapeutics has temporarily paused patient dosing and screening in its Phase 3 MAGNITUDE and MAGNITUDE-2 trials for nex-z, a CRISPR-based therapy for transthyretin amyl... Read More